Taylor ZL; Thompson LE; Bear H; Mizuno T; Vinks AA; Ramsey LB. Toward pharmacogenetic SLCO1B1-guided dosing of methotrexate in arthritis using a murine Slco1b2 knockout model. Clinical and Translational Science. 2021; 14(6):2267-2277.

Dong M; Rodriguez AV; Blankenship CA; McPhail G; Vinks AA; Hunter LL. Pharmacokinetic modelling to predict risk of ototoxicity with intravenous tobramycin treatment in cystic fibrosis. Journal of Antimicrobial Chemotherapy. 2021; 76(11):2923-2931.

Tang Girdwood S; Dong M; Tang P; Stoneman E; Jones R; Yunger T; Ostermeier A; Curry C; Forton M; Hail T. Population Pharmacokinetic Modeling of Total and Free Ceftriaxone in Critically Ill Children and Young Adults and Monte Carlo Simulations Support Twice Daily Dosing for Target Attainment. Antimicrobial Agents and Chemotherapy. 2022; 66(1):e0142721-.

van Hoogdalem MW; Johnson TN; McPhail BT; Kamatkar S; Wexelblatt SL; Ward LP; Christians U; Akinbi HT; Vinks AA; Mizuno T. Physiologically-Based Pharmacokinetic Modeling to Investigate the Effect of Maturation on Buprenorphine Pharmacokinetics in Newborns with Neonatal Opioid Withdrawal Syndrome. Clinical Pharmacology and Therapeutics. 2022; 111(2):496-508.

Mizuno K; Dandoy CE; Teusink-Cross A; Davies SM; Vinks AA; Jodele S. Eculizumab precision-dosing algorithm for thrombotic microangiopathy in children and young adults undergoing HSCT. Blood Advances. 2022; 6(5):1454-1463.